New FDA-Cleared Blood Pressure Monitor from Tenovi Supports Maternal Care and Stroke Prevention
PORTSMOUTH, N.H.--(BUSINESS WIRE)--May is National Stroke Awareness Month, a time to recognize the signs of stroke and emphasize timely medical care. In the U.S., someone has a stroke every 40 seconds, yet many strokes are preventable when early warning signs are detected and addressed.¹ Remote patient monitoring (RPM) helps clinicians detect early warning signs by providing continuous access to vital signs and real-time health data between office visits.
As part of its commitment to preventive, accessible healthcare, Tenovi is launching the new Tenovi cellular-connected blood pressure monitor with irregular heartbeat detection, for use with Tenovi's large-size cuff. It is FDA-cleared for use in maternity care and for adults with diabetes, pregnancy, or preeclampsia.
Stroke is often linked to unmanaged chronic conditions such as hypertension. With 129 million Americans living with chronic illnesses, Tenovi is committed to closing care gaps and making preventive, proactive healthcare the norm.²
Tenovi recently advanced that mission by completing the AgeTech Collaborative™ from AARP Accelerator Program, an 8-week program designed to elevate promising early-stage AgeTech startups.
'Tenovi fully supports the mission of the AgeTech Collaborative™ from AARP to improve lives as people age,' said Nizan Friedman, Ph.D., CEO and co-founder of Tenovi. 'Our platform offers a seamless pathway for companies focused on better health outcomes to scale quickly through our network of over 180 remote patient monitoring partners. This collaboration expands access to innovative point solutions for seniors and reinforces our commitment to delivering comprehensive remote care across all disease states.'
Tenovi's remote monitoring platform enables clinicians to act early when warning signs, such as rising blood pressure may surface. Tenovi's proprietary Cellular Gateway connects over 40 FDA-cleared Bluetooth remote monitoring devices for vital signs, medication adherence, and activity tracking. The plug-and-play platform requires no apps, Wi-Fi, or syncing, and uses a simple red and green LED display system for added measurement adherence. The red light signals it's time for a patient to take a measurement. The green light confirms it was transmitted to their care team.
As Stroke Awareness Month continues, Tenovi remains focused on delivering real-time remote patient and therapeutic monitoring solutions that help prevent complications and improve outcomes for patients most at risk.
About Tenovi
Tenovi is a data aggregation and automation remote monitoring platform connecting medical device manufacturers with remote monitoring programs. It provides over 40 remote patient monitoring and remote therapeutic monitoring (RTM) device point solutions that integrate with its proprietary Cellular Gateway, automating the transfer of patient vitals. Tenovi's API-driven fulfillment and automation services enable seamless deployment of remote patient and therapeutic monitoring programs. To learn more, visit www.tenovi.com or follow on LinkedIn @tenovi, X @tenovihealth.
Sources
2 Hirsch, S. P., & Smith, L. M. (2024). Implementation of remote physiologic monitoring and remote therapeutic monitoring into a primary care practice to improve outcomes for patients with diabetes. Virginia, 2021–2023. Preventing Chronic Disease, 21, E20. Centers for Disease Control and Prevention. https://www.cdc.gov/pcd/issues/2024/23_0267.htm
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
17 minutes ago
- Newsweek
Gen Z's Trauma Therapy Compared to Millennials, Boomers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Gen Z may have a reputation for being the weakest generation, but their trauma therapy habits indicate they are not too different from their millennial and Gen-X elders. Baby Boomers, however, show a reluctance to seek help for traumatic experiences. In a new report from Rula Health, Americans' therapy habits were analyzed by generation. Baby Boomers' reluctance for trauma therapy may be defined by their upbringing. "Their reluctance to seek trauma therapy reflects a generation that was told to suck it up, repress everything, and call it strength," Driscoll told Newsweek. Why It Matters Gen Z, which includes those aged roughly from 12 to 28, has been reported as more likely to deal with mental health issues, with some employers and elders seeing them as a "softer" generation. A survey by Talker Research for Traditional Medicinals found that 19 percent of respondents under 18 had taken a mental health day in the past few weeks alone. Meanwhile, 65 percent of Baby Boomers said they had never called in sick due to stress. Additionally, a 2023 Gallup survey found that just 15 percent of Gen Zers reported their mental health as excellent, a substantial drop from the decade before when 52 percent of millennials in the same age range reported their mental health as excellent. Elyssa Thelin, a substance use disorder counselor and art therapist at the Cielo Treatment Center, talks about how people use art as therapy for their feelings and trauma at the Cielo Treatment Center for drug... Elyssa Thelin, a substance use disorder counselor and art therapist at the Cielo Treatment Center, talks about how people use art as therapy for their feelings and trauma at the Cielo Treatment Center for drug addiction rehabilitation and mental health in Portland, Oregon on January 24, 2024. More PATRICK T. FALLON/AFP via Getty Images What To Know When it comes to the generations and trauma therapy, there are fewer differences than one might expect. The new Rula Health report found those aged 18 to 24 (considered older Gen-Zers) sought therapy due to trauma 31.6 percent of the time, with those aged 25 and 34 (oldest of Gen-Z and the younger half of millennials) also seeking help for trauma at 30.8 percent. Even in the older age group of 45 to 54 (Gen-X), 30.1 percent reported they were going to therapy for trauma. The number only significantly dipped off at age 55 to 64 (the oldest of Gen-X and younger Boomers), when only 16.9 percent were in therapy for trauma, and even less, 10.3 percent of those aged 65 and older (Baby Boomers) said they went to therapy due to trauma. This reflects that Baby Boomers are the real outlier when it comes to their views on trauma and therapy, said Bryan Driscoll, an HR consultant who specializes in generational differences. "Their reluctance to seek trauma therapy reflects a generation that was told to suck it up, repress everything, and call it strength," Driscoll told Newsweek. "But unaddressed trauma doesn't go away - it just turns into bad parenting, addiction, rage, and broken families. Boomers don't dodge therapy because they're tougher than younger generations. They dodge therapy because they've been shamed out of it." Relationship therapist Joy Berkheimer, who is also the founder of Joy Collective, echoed this sentiment. "The reluctance among many Boomers to seek therapy reflects deeper cultural, societal, and historical contexts," Berkheimer told Newsweek. "They were raised in a time where mental health stigma was stronger, and seeking help could be seen as a sign of failure or weakness." Across the board, 54 percent of those in therapy were seeking it for help with anxiety, with 52.9 percent going due to depression. A similar rate to those in therapy for trauma (26.8 percent) were seeing a professional for stress or burnout at 33.1 percent. Those aged 45 to 54 reported the highest rates of anxiety and burnout, while those aged 55 to 64 showed the highest rates of depression. What People Are Saying Bryan Driscoll, an HR consultant who specializes in generational differences, told Newsweek: "This data doesn't show Gen Z and other younger generations are weak. It shows they're more self-aware and more willing to confront pain head-on, rather than bury it under a 'just deal with it' mentality. What people too often label as weakness is actually emotional literacy. Older generations were raised to believe therapy was for people who were broken. Gen Z knows it's for people who want to break cycles." Monica Cwynar, a licensed counselor and social worker with Thriveworks, told Newsweek: "Baby boomers (ages 55–64) and older generations show much lower rates of therapy-seeking behavior, particularly at only 16.9 percent. Their lower rate of engagement can reflect a cultural background shaped by different societal norms around mental health, where there has traditionally been a stigma associated with seeking help. Boomers are more likely to emphasize resilience, self-reliance, and the belief that personal struggles should be handled privately, that seeking help is a weakness, resulting in a hesitance to seek external support like therapy." Relationship therapist Joy Berkheimer, also the founder of Joy Collective, told Newsweek: "The data clearly does not support the narrative that Gen Z is 'weaker.' Instead, it shows that all generations are increasingly recognizing the importance of mental health, though their methods and comfort levels differ. What we're witnessing is a shift in cultural norms: more openness, less stigma, and greater access." What Happens Next Berkheimer said on a larger level, Gen Z is breaking down the stigmas around mental health and trauma, which could impact how people engage with therapy moving forward. "This generation is more likely to openly seek therapy, prioritize emotional well-being, and engage in practices that emphasize healing and self-awareness... In contrast, older generations may have been conditioned to view therapy as a last resort or a sign of weakness, often due to cultural and societal taboos rooted in stigma and distrust."
Yahoo
18 minutes ago
- Yahoo
DIA to Celebrate 9 Life Sciences Leaders at DIA 2025 Global Annual Meeting in Washington
EMA's Emer Cooke, former FDA Commissioner Dr. Robert Califf to be recognized among new Fellows of DIA and annual Global Inspire Award winners, with special keynote from global health leader Dr. Larry Brilliant and live performance from Grammy-nominated artist Aloe Blacc WASHINGTON, June 04, 2025--(BUSINESS WIRE)--DIA, a global non-profit organization of life sciences professionals, will induct four Fellows of DIA and recognize six recipients of Global Inspire Awards and America's Inspire Awards on June 15 as part of the DIA 2025 Global Annual Meeting — including Emer Cooke, Executive Director of the European Medicines Agency (EMA), who is receiving both honors. Fellows of DIA are long-serving members recognized for their sustained dedication to advancing healthcare. The Global Inspire Awards recognize honorees who have made outstanding improvements to global health while adhering to DIA's mission. "These distinguished individuals have made enduring contributions to the life sciences reflecting DIA's values and purpose," said Marwan Fathallah, DIA's President and Chief Executive Officer. "Their work in regulatory science, research, and global collaboration exemplifies the spirit of innovation that drives our mission forward." Cooke has been the EMA's Executive Director and the Chair of the International Coalition of Medicines Regulatory Authorities (ICMRA) since November 2020. She has more than 30 years of experience in international regulatory affairs, including four years as the director responsible for medical product-related regulatory activities at the World Health Organization (WHO). Dr. Robert M. Califf, who served as the Commissioner of the U.S. Food and Drug Administration (FDA) from February 2016 to January 2017 and February 2022 to January 2025, is also being recognized as a Fellow of DIA. A nationally recognized expert in cardiovascular medicine and health outcomes research, he has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science. Dr. Califf became a Member of the National Academy of Medicine in 2016. Dr. Michael Rosenblatt and Dr. Hironobu Saito are also being named Fellows of DIA. Rosenblatt, a Senior Partner at Flagship Pioneering and the Immediate Past Chair of DIA's Board of Directors, has advanced biopharmaceutical research and development throughout his career. He was previously Merck's Chief Medical Officer and the Dean of the Tufts University School of Medicine. Saito, a Specially Appointed Professor at Tottori University's Chromosome Engineering Research Center, spent 35 years in drug development at Daiichi Sankyo and has contributed to DIA Japan for more than two decades. In addition to Cooke, who will be presented with the Global Award for Outstanding Contribution to Health, six members of the health and life sciences community will receive Global Inspire Awards: — Kazumichi Kobayashi, Executive Deputy President at Otsuka Medical Device, will be honored with the Global Connector Award for advancing DIA's mission and promoting global collaborations. Kobayashi, who has served in various senior positions in research and development at Otsuka Pharmaceutical Co., previously led DIA Japan and chaired the DIA Advisory Council of Japan. — Cary Smithson will receive the Community Engagement Award as a DIA Community Chair who consistently drives engagement while advancing knowledge and thought leadership. Smithson, a Managing Partner at LeapAhead Solutions, leads DIA's Regulatory Affairs Community and Regulatory Information Management (RIM) Intelligent Automation Team, and co-leads its RIM Working Group. —Jennifer B. Christian will be named the Author of the Year, an award given to individuals whose article made the greatest impact on readership based on the number of downloads reported by Therapeutic Innovation & Regulatory Science (TIRS) in the preceding issue year. Her article, co-authored with Mehmet Burcu, Cyntia B. Manzano-Salgado, Anne M. Butler, "A Framework for Extension Studies Using Real-World Data to Examine Long-Term Safety and Effectiveness," was downloaded more than 12,400 times. Global Inspire Award recipients, except for the Author of the Year, must be nominated by two active DIA members to be considered candidates. They undergo a thorough review process before a committee of Fellows of DIA selects the winners. DIA will also recognize the regional Inspire Awards winners from the Americas: — David Fryrear, Chief Quality Officer at Astellas Pharma, will receive the Excellence in Service Award as a DIA volunteer who has significantly contributed to the advancement of the organization's mission. He previously held senior roles at AbbVie and Eli Lilly and Company and spent much of his career developing and improving quality systems. — Elma Abdulbaki, a PharmD student at the University of Illinois at Chicago and President of the DIA National Student Board, will be honored with the Leader of Tomorrow Award for her outstanding contributions as a young professional in the healthcare field. In addition to these awards and recognitions, there will be a performance by Grammy-nominated artist and songwriter Aloe Blacc. Renowned physician, epidemiologist, and global health leader Dr. Larry Brilliant will keynote at the event. Tickets for the awards ceremony are available to the public for the first time and can be purchased by clicking here. These honors will be presented in conjunction with the DIA 2025 Global Annual Meeting, the world's preeminent multidisciplinary life sciences forum held June 15-19 at the Walter E. Washington Convention Center in Washington. Click here to register or view the DIA 2025 event program. Media members may request credentials by emailing diaglobal@ About DIADIA is a leading global non-profit life science membership association that drives collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries. Learn more at and connect with DIA on LinkedIn, Facebook, X (Twitter), and Instagram. View source version on Contacts Media Katie KennedyGregory FCAdiaglobal@ 610-731-1045 Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Epoch Times
25 minutes ago
- Epoch Times
Trump's Megabill to Change Obamacare: What to Watch
A Republican megabill to enact President Donald Trump's agenda The ACA Marketplace, often referred to as Obamacare, allows low-income Americans to buy
